Moyamoya disease exhibits significant regional variations in incidence and clinical presentation, with higher rates in Japan and China compared to Taiwan and North America.
May inform region-specific MMD evaluation; confirms incidence disparities while leaving symptom variations unexplained.
MMD incidence was higher in Japan and China than in Taiwan and North America and presenting symptoms showed regional differences, which are thus far unexplained. Population based data on MMD in Europe are lacking.
No takes yet. Share an insight, caveat, or question.
Kleinloog et al. (2012) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: